Krystal Biotech, Inc. (KRYS)
266.04
+3.78
(+1.44%)
USD |
NASDAQ |
May 01, 16:00
266.24
+0.20
(+0.08%)
After-Hours: 20:00
Krystal Biotech Market Cap : 7.831B for May 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Scholar Rock Holding Corp. | 5.327B |
| Stoke Therapeutics, Inc. | 1.957B |
| Moderna, Inc. | 17.99B |
| Alnylam Pharmaceuticals, Inc. | 39.51B |
| TG Therapeutics, Inc. | 5.405B |
Market Cap Related Metrics
| PE Ratio | 38.87 |
| PS Ratio | 20.46 |
| PEG Ratio | 0.3012 |
| Price to Book Value | 6.421 |
| Price to Free Cash Flow | 42.14 |
| Price | 266.04 |
| Earnings Yield | 2.57% |
| PEGY Ratio | 0.3012 |
| Operating PE Ratio | 49.41 |
| Normalized PE Ratio | 38.87 |